The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Merck Serono; MSD Oncology; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Bayer Schering Pharma; Bristol-Myers Squibb; Merck Serono; MSD Oncology; Roche/Genentech
Research Funding - Merck Serono (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Bayer Schering Pharma; Merck Serono; MSD Oncology; Roche/Genentech
EORTC-1203 GITC "INNOVATION": Integration of trastuzumab (T), with or without pertuzumab (P), into perioperative chemotherapy of HER-2 positive stomach cancer: Overall survival results.
 
Anna Wagner
Consulting or Advisory Role - Astellas Pharma (Inst); AstraZeneca (Inst); BMS (Inst); MSD Oncology; Pierre Fabre (Inst)
Research Funding - Roche (Inst)
Travel, Accommodations, Expenses - Merck (Inst)
 
Heike Grabsch
No Relationships to Disclose
 
Murielle Mauer
Research Funding - Educational grant from Roche (Inst)
 
Sylvie Lorenzen
No Relationships to Disclose
 
Olivier Bouche
Consulting or Advisory Role - Amgen; Apmonia Therapeutics; Astellas Pharma; Deciphera; MSD Oncology; Pierre Fabre; SERVIER; Takeda
Speakers' Bureau - Amgen; Deciphera; Merck Serono; MSD Oncology; Pierre Fabre; Servier
Travel, Accommodations, Expenses - Pierre Fabre; Servier; Takeda
 
Peter Thuss-Patience
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Meyers-Squibb; Daiichi Sankyo; Lilly; Merck Serono; MSD; Novartis; Pfizer; Roche; SERVIER
Research Funding - Merck/Pfizer (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Merck Serono
 
Anneli Elme
Consulting or Advisory Role - Amgen; AstraZeneca; MSD Oncology
Travel, Accommodations, Expenses - MSD; Swixx BioPharma
 
Markus Moehler
Honoraria - Amgen; Astellas Pharma; AstraZeneca/MedImmune; Bayer Schering Pharma; Bristol-Myers Squibb; Daiichi Sankyo Europe GmbH; Idience; Merck Serono; MSD Oncology; Pierre Fabre; Roche/Genentech; Sanofi; Servier; Transcenta; Triptych Health Partners
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; BeiGene; BMS; Daiichi Sankyo Europe GmbH; Lilly; Merck Serono; MSD; Nordic Group; SERVIER; Taiho Pharmaceutical; Takeda
Research Funding - Amgen (Inst); AstraZeneca (Inst); Leap Therapeutics (Inst); Merck Serono (Inst); MSD (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Amgen; ASCO; Bayer; BeiGene; ESMO; German Cancer Society; Merck Serono; MSD; Roche; Sanofi Pasteur
 
Uberto Fumagalli Romario
Employment - Società Ossigeno Liquido - Vivisol (I)
Leadership - Società Ossigeno Liquido - Vivisol (I)
Stock and Other Ownership Interests - Società Ossigeno Liquido - Vivisol
 
Yoon-Koo Kang
Consulting or Advisory Role - DAEHWA Pharmaceutical; HLB
 
Gunnar Folprecht
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Daichi; Exact Sciences; GlaxoSmithKline; Incyte; Janssen; Merck KGaA; Merck Sharp & Dohme; Pierre Fabre; Pierre Fabre; Roche/Genentech; SERVIER; Takeda
Research Funding - Merck KGaA (Inst)
 
Uwe Martens
Stock and Other Ownership Interests - Lilly; Novo Nordisk
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Guardant Health; MSD Oncology; Roche
Travel, Accommodations, Expenses - Ipsen; Janssen Oncology; Lilly; Pierre Fabre
 
Maica del Carmen Galan Guzman
No Relationships to Disclose
 
Valerie Boige
No Relationships to Disclose
 
Marc Díez Garcia
No Relationships to Disclose
 
Guillaume Piessen
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Daiichi Sankyo/Lilly; Elivie; MSD Oncology; Nestle health science; Stryker
Travel, Accommodations, Expenses - medtronic; MSD Oncology
(OPTIONAL) Uncompensated Relationships - Medtronic
 
Maike Collienne
Research Funding - Abbvie (Inst); Iovance Biotherapeutics (Inst); MSD (Inst); PharmaMar (Inst); Roche (Inst); SERVIER (Inst)
 
Stephanie Antunes
No Relationships to Disclose
 
Florian Lordick
Honoraria - Art Tempi; Astellas Pharma; AstraZeneca; BioNTech; Bristol-Myers Squibb; Daiichi Sankyo Europe GmbH; Falk Foundation; Incyte; Lilly; Medscape; Medupdate; Merck KGaA; Merck Sharp & Dohme; Novartis; Roche; SERVIER; Streamedup!
Consulting or Advisory Role - Astellas Pharma; Boehringer Ingelheim; Bristol-Myers Squibb; Daichi Sankyo; Merck Sharp & Dohme; PAGE
Research Funding - Gilead Sciences (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Lilly